BlueDot
bluedot.global
Predictive Analytics
Medical AI
Public Health & Prevention
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
BlueDot is a Toronto company founded in 2013 that tracks infectious disease risk using machine learning over news reports, official bulletins, flight itineraries and climate data. It became widely known for flagging the outbreak that became COVID-19 in the final days of 2019, ahead of public health announcements. Governments, hospitals and businesses use its surveillance and forecasting products to prepare for emerging threats.
News
Strategies on Emerging Pathogens for Infection Preventions Infection Control Today
A presentation at APIC 2024 will feature strategies for combating emerging pathogens, emphasizing preparedness for infection preventionists amid rising global health threats, including dengue, measles, and new unknown pathogens.
Read more
Report
Estimating true size of the Ebola Bundibugyo virus disease outbreak in the Democratic Republic of Congo as of June 9, 2026
Updated from the May 22, 2026 report.This free report examines the likely true size of the current Ebola Bundibugyo virus disease outbreak in the Democratic Republic of the Congo (DRC).Official figures likely underestimate the scale of the outbreak, which
Read more
Report
Your Risk Map Is Outdated: What the 2026 World Cup Reveals About the New Travel Health Landscape
The World Cup is a massive event that will expose how profoundly the infectious disease landscape has changed in recent years. Organizations dealing with static assumptions about disease threats may be caught by surprise. On June 11, the 2026 World Cup ki
Read more
Report
What can we learn from Measles in the US?
The largest US measles outbreak in over 25 years is unfolding, exposing a complex dynamic between risk, hesitancy and vaccination. Organizations everywhere can learn much from it. Nestled between the bigger cities of Charlotte and Greenville, Spartanburg
Read more
Report
BlueDot Meetings Enters the Video Meeting Market with Focus on Security and Seamless AI-Powered Language Translation, taking on Zoom and Microsoft Teams
Read more
Report
Beware the "Superflu" hype: How infectious disease surveillance goes beyond the headlines
When it comes to outbreaks, media reporting is a critical resource-but its trade-offs cannot be ignored In 2025, country after country reported a significant rise in influenza infections, often a full month earlier than the typical start to the flu season
Read more
Report
Tracking Infectious Threats: Key Outbreaks of 2025 and Risks for 2026
The global infectious disease landscape is shifting faster than ever. In 2025, outbreaks and influenza-like illnesses (ILI) spread unpredictably, testing public health systems and organizational preparedness. As we head into 2026, knowing which signals tr
Read more
Report
The most notable infectious disease events of 2025
Three battles we fought - and another we won - against emerging threats and resurgent foes over the past year From unexpected outbreaks that challenged global health systems to groundbreaking advancements in disease surveillance and prevention, this past
Read more
Report
How data blackouts and blind spots put organizations at risk
The U.S. government shutdown demonstrates how infectious disease data sources can dry up - and how third-party surveillance sees in the dark The recent US government shutdown, lasting 43 days and furloughing around 670,000 federal employees, disrupted a m
Read more
Report
Local Matches, Global Risks: Infectious Disease Surveillance, Connectivity and the 2026 World Cup
We have entered a new era of global mobility - one where mass gatherings and interconnected travel networks can rapidly amplify infectious disease risks. As the 2026 World Cup approaches, how can local public health teams prepare for the challenges that l
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Toronto
Canada
HQ
Financials
Total raised
$9.1M
Latest round
Series B
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series B | 2020 | $9.1M | Details |